Skip to main content
. 2020 Jun 30;9(1):1788252. doi: 10.1080/2162402X.2020.1788252

Figure 5.

Figure 5.

Association of signature 1 with tumor mutation burden in pooled TNBC cohort.

Tumor mutation burden (a) and neoantigen burden (b) were stratified by mutational signature 1. (c) Multivariate logistic regression analysis of signature 1 mutation with TMB after adjusted for age, grade, histological type, lymph node, mutational signatures, and mutations in BRCA1/2 and ATR. Square data markers indicated estimated hazard ratios. Error bars represent 95% CIs.